Author name: Ying Mak

Cambridge Cognition unveils strategic partnership for Chinese market expansion

News Back to resource centre 24 November 2022 Cambridge Cognition unveils strategic partnership for Chinese market expansion Cambridge Cognition is pleased to announce an expansion in the Chinese market through a strategic partnership with Luca Healthcare Limited, a category leader in digital screening, treatment and management tools in China. Cambridge Cognition has signed an exclusive licencing agreement with Luca Healthcare

Cambridge Cognition unveils strategic partnership for Chinese market expansion Read More »

Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition

News Back to resource centre 12 October 2022 Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition Cambridge Cognition has entered an agreement to acquire eClinicalHealth Ltd; a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.Catalysed by the pandemic, the overall virtual clinical trials market has

Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition Read More »

Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers

Webinars Back to resource centre 11 January 2023 Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers During the COVID-19 pandemic, healthcare workers have been exposed to substantial amounts of stress, with a negative impact on their mental and physical health. The 4YouandMe Stress and Recovery in Frontline Healthcare Covid-19 Workers Study aimed to understand how different facets

Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers Read More »

Reflections on my industry placement at Cambridge Cognition

Insights Back to resource centre 23 September 2022 Reflections on my industry placement at Cambridge Cognition PhD student Rachel Lees joined Cambridge Cognition on an industry placement in May 2022. Here she reflects on her experience.I am currently a 3rd year PhD student, studying Psychology at the University of Bath. In May 2022, I took a 2-week break from my

Reflections on my industry placement at Cambridge Cognition Read More »

Successful Statistical Strategies for Patient Screening and Stratification

Webinars Back to resource centre 11 January 2023 Successful Statistical Strategies for Patient Screening and Stratification Purposeful consideration of statistical analysis can be hugely beneficial for clinical studies by increasing the potential to detect an efficacy signal and reducing the signal-to-noise ratio. Pre-screening and patient stratification are two methods that can be used to help drive efficiencies and boost the statistical

Successful Statistical Strategies for Patient Screening and Stratification Read More »

Decentralised Trials in Psychiatry: From Feasibility to Novel Insights

Webinars Back to resource centre 11 January 2023 Decentralised Trials in Psychiatry: From Feasibility to Novel Insights As we move towards decentralized and hybrid trial designs, it is increasingly important to understand the feasibility and reliability of digital measurement tools.Here, experts from Otsuka and Cambridge Cognition shared insights from a recent collaborative study, discussing the value of remote monitoring of

Decentralised Trials in Psychiatry: From Feasibility to Novel Insights Read More »

Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond

Webinars Back to resource centre 11 January 2023 Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond Despite considerable efforts by biopharmaceutical companies, late-stage trial failures have plagued the drug development process for targeting Alzheimer’s disease. So what’s the problem? Join Dr. Kenton Zavitz and Dr Robert Smith to discuss the issues surrounding the identification of patients for these early

Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond Read More »

Neuroscience & Biobehavioral Reviews | Social cognition: an important but overlooked aspect of cognitive function

Publications & posters Back to resource centre 11 January 2023 Social cognition: an important but overlooked aspect of cognitive function Social cognitive deficits have traditionally been linked with autism spectrum conditions. However, a recent paper from Cambridge Cognition suggests that deficits in social cognition are exhibited across a range of neurological, psychiatric and developmental disorders.Our ability to understand the thoughts

Neuroscience & Biobehavioral Reviews | Social cognition: an important but overlooked aspect of cognitive function Read More »

What is test-retest reliability and why is it important?

Insights What is test-retest reliability and why is it important? 15 September 2016 Back to resource centre Digital Health & Innovation Scientist, Matthew Hobbs explores what test re-test reliability is, how you would measure it and why it is important when choosing cognitive tests. What is test re-test reliability? When you come to choose the measurement tools for your experiment,

What is test-retest reliability and why is it important? Read More »

Scroll to Top